Jeremy Nathan Block

JEREMY BLOCK is a faculty member at the Marxe School of Public and International Affairs at Baruch College, CUNY where he teaches courses on Ethics, Race & Inequality, and Science & Technology Policy.  Dr. Block concurrently serves as the Medical Office & Regulatory Science Strategy Director for the global technology company Dassault Systemes. In addition, he serves on the clinical trials ethics boards (IRB) for MD Anderson Cancer Center, and Northwell Health. 

From 2017-2022 Jeremy was a co-founder of Medaptive Health (acquired in 2022), a clinical trial technology company where he led product, science, and regulatory functions.  From 2016-2021 Jeremy served as executive director of a digital health study performing population screening of genetic founder mutations at Memorial Sloan Kettering Cancer Center. Previously, Dr. Block was an Assistant Professor of Population Health Science & Policy at the Icahn School of Medicine at Mount Sinai where he was also an ethics board chairman (IRB) at hospitals within the Mount Sinai Health System. Prior roles include working for The City of New York in Procurement in the Bloomberg Administration, and with the Office of Management and Budget within the Executive Office of the President of the United States in the Bush and Obama Administrations. 

He holds a Bachelors in Chemistry & Biology, Masters in Public Policy, and Ph.D. in Biochemistry from Duke University.